Impact of treatment delays on outcomes of primary percutaneous coronary intervention for acute myocardial infarction: Analysis from the CADILLAC trial

The impact of treatment delays on outcomes after primary percutaneous coronary intervention for acute myocardial infarction is controversial. The CADILLAC trial randomized 2082 patients with acute myocardial infarction to stenting versus percutaneous transluminal coronary angioplasty, each with or w...

Full description

Saved in:
Bibliographic Details
Published in:The American heart journal 2006-06, Vol.151 (6), p.1231-1238
Main Authors: Brodie, Bruce R., Stone, Gregg W., Cox, David A., Stuckey, Thomas D., Turco, Mark, Tcheng, James E., Berger, Peter, Mehran, Roxana, McLaughlin, Michael, Costantini, Costantino, Lansky, Alexandra J., Grines, Cindy L.
Format: Article
Language:English
Subjects:
Aged
Angioplasty, Balloon, Coronary
Biological and medical sciences
Cardiology. Vascular system
Clinical outcomes
Coronary heart disease
Diabetes
Female
Heart
Heart attacks
Heart surgery
Humans
Hypertension
Male
Medical imaging
Medical sciences
Mortality
Myocardial Infarction - mortality
Myocardial Infarction - surgery
Myocarditis. Cardiomyopathies
Stents
Survival Rate
Time Factors
Treatment Outcome
Veins & arteries
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The impact of treatment delays on outcomes after primary percutaneous coronary intervention for acute myocardial infarction is controversial. The CADILLAC trial randomized 2082 patients with acute myocardial infarction to stenting versus percutaneous transluminal coronary angioplasty, each with or without abciximab. Earlier reperfusion (6 hours) was associated with lower 1-year mortality (2.6% vs 4.3% vs 4.8%, P = .046 for
ISSN:0002-8703
1097-6744
DOI:10.1016/j.ahj.2005.07.016